4.5 Article

BBS1 branchpoint variant is associated with non-syndromic retinitis pigmentosa

Journal

JOURNAL OF MEDICAL GENETICS
Volume 59, Issue 5, Pages 438-444

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jmedgenet-2020-107626

Keywords

eye diseases; human genetics; molecular biology; ophthalmology

Funding

  1. Foundation Fighting Blindness USA Project Program Award [PPA-0517-0717-RAD]
  2. Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Oogfonds, Landelijke Stichting voor Blinden en Slechtzienden
  3. Rotterdamse Stichting Blindenbelangen
  4. Stichting Blindenhulp
  5. Stichting tot Verbetering van het Lot der Blinden
  6. Stichting Blinden-Penning
  7. Fighting Blindness Ireland [FB18CRE]
  8. Wellcome Trust [219607/Z/19/Z]
  9. Royal College of Surgeons (Edinburgh)
  10. Health Education England Genomics Education Programme (HEE GEP)
  11. Wellcome Trust [219607/Z/19/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

Through whole genome sequencing and functional analysis, a branchpoint variant in BBS1 was identified, resulting in non-syndromic RP in four unrelated individuals. This study highlights the importance of analyzing non-coding regions to provide a conclusive molecular diagnosis.
Background Inherited retinal diseases (IRDs) can be caused by variants in >270 genes. The Bardet-Biedl syndrome 1 (BBS1) gene is one of these genes and may be associated with syndromic and non-syndromic autosomal recessive retinitis pigmentosa (RP). Here, we identified a branchpoint variant in BBS1 and assessed its pathogenicity by in vitro functional analysis. Methods Whole genome sequencing was performed for three unrelated monoallelic BBS1 cases with non-syndromic RP. A fourth case received MGCM 105 gene panel analysis. Functional analysis using a midigene splice assay was performed for the putative pathogenic branchpoint variant in BBS1. After confirmation of its pathogenicity, patients were clinically re-evaluated, including assessment of non-ocular features of Bardet-Biedl syndrome. Results Clinical assessments of probands showed that all individuals displayed non-syndromic RP with macular involvement. Through detailed variant analysis and prioritisation, two pathogenic variants in BBS1, the most common missense variant, c.1169T>G (p.(Met390Arg)), and a branchpoint variant, c.592-21A>T, were identified. Segregation analysis confirmed that in all families, probands were compound heterozygous for c.1169T>G and c.592-21A>T. Functional analysis of the branchpoint variant revealed a complex splicing defect including exon 8 and exon 7/8 skipping, and partial in-frame deletion of exon 8. Conclusion A putative severe branchpoint variant in BBS1, together with a mild missense variant, underlies non-syndromic RP in four unrelated individuals. To our knowledge, this is the first report of a pathogenic branchpoint variant in IRDs that results in a complex splice defect. In addition, this research highlights the importance of the analysis of non-coding regions in order to provide a conclusive molecular diagnosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available